Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
Open Access
- 10 November 2011
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 11 (1) , 305
Abstract
Background: To characterize healthcare resource utilization and costs in patients with metastatic lung cancer receiving chemotherapy in the US. Methods: Using data from a large private multi-payer health insurance claims database (2000-2006), we identified all patients beginning chemotherapy for metastatic lung cancer. Healthcare resource use (inpatient, outpatient, medications) and costs were tallied over time from date of therapy initiation ("index date") to date of disenrollment from the health plan (in most instances, presumably due to death) or the end of the study period, whichever occurred first. Healthcare utilization and costs were characterized using Kaplan-Meier sample average methods. Results: The study population consisted of 4068 patients; mean (SD) age was 65 (11) years. Over a median follow-up of 334 days, study subjects averaged 1.5 hospital admissions, 8.9 total inpatient days, and 69 physician office and hospital outpatient visits. Mean (95% CI) cumulative total healthcare costs were $125,849 ($120,228, $131,231). Costs of outpatient medical services and inpatient care constituted 34% and 20% of total healthcare costs, respectively; corresponding estimates for outpatient chemotherapy and other medication were 22% and 24%. Conclusion: Our study sheds additional light on the burden of metastatic lung cancer among patients receiving chemotherapy, in terms of total cost thru end of life as well as component costs by setting and type of service, and may be useful in informing medical resource allocation in this patient population.Keywords
This publication has 11 references indexed in Scilit:
- Marine Edible Algae as Disease Preventers2011
- Costs of First-Line Doublet Chemotherapy and Lifetime Medical Care in Advanced Non–small-Cell Lung Cancer in the United StatesValue in Health, 2009
- Metastatic non-small cell lung cancer: costs associated with disease progression.2008
- Cost of Care for Elderly Cancer Patients in the United StatesJNCI: Journal of the National Cancer Institute, 2008
- The value of medical interventions for lung cancer in the elderlyCancer, 2007
- Health care costs for the treatment of breast cancer recurrent events: estimates from a UK-based patient-level analysisBritish Journal of Cancer, 2007
- Differences in Health Care Utilization at the End of Life Among Patients With Chronic Obstructive Pulmonary Disease and Patients With Lung CancerArchives of internal medicine (1960), 2006
- The economic burden of lung cancer and the associated costs of treatment failure in the United StatesLung Cancer, 2005
- The Utility of Medicare Claims Data for Measuring Cancer StageMedical Care, 1999
- Bootstrap Methods: Another Look at the JackknifeThe Annals of Statistics, 1979